Latest Commercial Contracts News

Page 2 of 15
RocketDNA’s unaudited Q3 FY26 revenue rose 31% year-on-year to A$2.46 million, while xBot recurring revenue exceeded half of group revenue for the first time. The shift comes alongside expanding deployments, a A$2.23 million placement and continued cash investment in the platform.
Sophie Babbage
Sophie Babbage
29 Oct 2026
Suncorp expects FY27 gross written premium growth of around 3%, despite losing a $125 million commercial contract and facing a weaker New Zealand dollar. The insurer maintained its forecast for an underlying insurance trading result margin in the top half of its 10-12% target range and confirmed a $250 million buyback is underway.
Victor Sage
Victor Sage
29 Oct 2026
Metallium has signed a non-binding MOU with global commodity trader Traxys to explore feedstock, processing, offtake and financing opportunities for U.S. critical metals. The framework could improve the path to commercial scale, but it contains no binding volumes, prices, funding or sales commitments.
Victor Sage
Victor Sage
26 Oct 2026
PainChek has expanded its Sabra relationship from two initial facilities to 23 US communities across five operators, covering 808 contracted memory care licences. The immediate test is whether those contracts become implemented recurring revenue by the end of 2026.
Victor Sage
Victor Sage
13 Oct 2026
Li-S Energy has signed an agreement to evaluate its Australian-made lithium-sulfur batteries in Safesky Systems' tactical drone platforms. The collaboration opens a potential defence supply pathway, but commercial orders remain dependent on testing and customer procurement decisions.
Victor Sage
Victor Sage
9 Oct 2026
Artrya has signed a five-year agreement with Huntsville Hospital Health System, converting the first participant in its SAPPHIRE Study into a commercial customer. The deal carries a minimum contracted value of US$0.5 million for Salix Coronary Anatomy, with further usage-based revenue possible from other modules.
Victor Sage
Victor Sage
2 Oct 2026
ClearVue Technologies reported just A$108,484 of FY2026 revenue against an A$11.86 million loss, while consuming A$8.69 million in operating cash. The solar-glazing developer says certifications, international partners and an 80-project pipeline have strengthened its platform, but the next test is converting those assets into cash revenue.
Victor Sage
Victor Sage
30 Sept 2026
Yojee enters FY27 with 12 signed MOSAIC customer agreements and $10.45 million in fresh funding, but the freight software company is still loss-making and yet to generate meaningful MOSAIC revenue. Management expects initial billings in the December quarter as it works to convert signed customers into live, billable usage.
Sophie Babbage
Sophie Babbage
30 Sept 2026
Viridis Mining and Minerals Limited (ASX:VMM) has used its FY2026 annual report to present Colossus as a rare earths project moving from study work into execution. The company has reported strong DFS economics and fresh equity funding, but still needs key permits, binding offtake and senior debt before construction can fully proceed.
Maxwell Dee
Maxwell Dee
28 Sept 2026
Embelton Limited (ASX:EMB) grew revenue, profit and operating cash flow in FY2026 despite subdued residential construction, while maintaining its 35-cent fully franked annual dividend. The flooring and engineering group is leaning further into infrastructure, data centres, healthcare and other commercial work, although its near-term contracting pipeline remains modest.
Victor Sage
Victor Sage
28 Sept 2026
Tamboran Resources has moved into initial Beetaloo gas sales, but its first annual report after the milestone still records no fiscal 2026 revenue, a $30.5 million loss and substantial doubt about its ability to continue as a going concern. The company held $219.1 million in cash at June 30, yet faces heavy development spending, no proved reserves and a material weakness in financial controls.
Maxwell Dee
Maxwell Dee
28 Sept 2026
Podium Minerals says optimisation work has maintained approximately 80% overall 3E recovery while cutting the targeted size of its downstream recovery circuit by about half. The technical gains came alongside a larger annual loss and an explicit reliance on further funding to advance Parks Reef.
Maxwell Dee
Maxwell Dee
24 Sept 2026

Browse the archive

Full archive